• Molecular NameSalmon Calcitonin
  • SynonymCalcitonin 1 precursor; Calcitonin-salmon; Calcitonin; salmon; salmon calcitonin; Salmotonin
  • Weight3431.91
  • Drugbank_IDDB00017
  • ACS_NON/A
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)N/A
  • pkaN/A
  • LogD (pH=7, predicted)N/A
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)N/A
  • LogSw (predicted, AB/LogsW2.0)N/A
  • Sw (mg/ml) (predicted, ACD/Labs)N/A
  • No.of HBond DonorsN/A
  • No.of HBond AcceptorsN/A
  • No.of Rotatable BondsN/A
  • TPSAN/A
  • StatusFDA approved
  • AdministrationNasal
  • PharmacologyN/A
  • Absorption_valueN/A
  • Absorption (description)Salmon calcitonin is rapidly absorbed and eliminated. Bioavailability following subcutaneous and intramuscular injection in humans is high and similar for the two routes of administration (71% and 66%, respectively).
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmSalmon calcitonin is primarily and almost exclusively degraded in the kidneys, forming pharmacologically inactive fragments of the molecule.
  • Half life50~80 min
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySalmon calcitonin is devoid of embryotoxic, teratogenic and mutagenic potential.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A